Reaction Details |
| Report a problem with these data |
Target | Cytochrome P450 3A4 |
---|
Ligand | BDBM200386 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2164346 (CHEMBL5049207) |
---|
IC50 | 11000±n/a nM |
---|
Citation | Poddutoori, R; Aardalen, K; Aithal, K; Barahagar, SS; Belliappa, C; Bock, M; Chelur, S; Gerken, A; Gopinath, S; Gruenenfelder, B; Kiffe, M; Krishnaswami, M; Langowski, J; Madapa, S; Narayanan, K; Pandit, C; Panigrahi, SK; Perrone, M; Potakamuri, RK; Ramachandra, M; Ramanathan, A; Ramos, R; Sager, E; Samajdar, S; Subramanya, HS; Thimmasandra, DS; Venetsanakos, E; Möbitz, H Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action. J Med Chem65:4350-4366 (2022) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cytochrome P450 3A4 |
---|
Name: | Cytochrome P450 3A4 |
Synonyms: | Albendazole monooxygenase | Albendazole sulfoxidase | CP3A4_HUMAN | CYP3A3 | CYP3A4 | CYPIIIA3 | CYPIIIA4 | Cytochrome P450 3A3 | Cytochrome P450 3A4 (CYP3A4) | Cytochrome P450 HLp | Nifedipine oxidase | Quinine 3-monooxygenase | Taurochenodeoxycholate 6-alpha-hydroxylase |
Type: | Enzyme |
Mol. Mass.: | 57349.57 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 503 |
Sequence: | MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF
DMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI
AEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS
MDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV
FPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI
IFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV
NETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS
KKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG
GLLQPEKPVVLKVESRDGTVSGA
|
|
|
BDBM200386 |
---|
n/a |
---|
Name | BDBM200386 |
Synonyms: | US10011599, Example 14 | US9227969, 14 | US9629836, 14 |
Type | Small organic molecule |
Emp. Form. | C28H24ClFN6O3 |
Mol. Mass. | 546.98 |
SMILES | Cc1nc2cnc3cc(F)c(cc3c2n1C1CCN(CC1)C(=O)CO)-c1ccc(Oc2ncccn2)cc1Cl |
Structure |
|